DJIA: 16,643.01  -11.76 (-0.07%) | NASDAQ: 4,828.325  +15.616 (0.32%) | S&P 500: 1,988.87  +1.21 (0.06%) Markets status unavailable

  • Show Article Details

    LONDON, Aug 27 (Reuters) - Britain's FTSE 100 index is seen opening up 111 to 127 points, or up to 2.1 percent higher on Thursday, according to financial bookmakers. For more on the factors affecting European stocks, please click on * The FTSE 100 index closed down 1.7 percent at 5,979.20 points, broadly in line with falls in European equities, on Wednesday, as fears about Chinese growth gnawed and a commodities sell-off rattled markets across Europe. * BARCLAYS - Major U.S. stock exchanges and Barclays Plc on Wednesday won the dismissal of nationwide litigation in which pension funds and other investors accused them of rigging markets to benefit high-frequency traders. * GLENCORE - Global mining and trading firm Glencore Plc and Australia's Bloomfield Group agreed to acquire Vale's Integra coal mine in Australia for undisclosed terms, the buyers said in an emailed statement on Wednesday. * SAINSBURY - British supermarket chain Sainsbury's will hand its 137,000 non-management store staff their highest pay increase in more than a decade this month, it said on Thursday, lifting its basic pay above the recently announced national living wage. * EX-DIVS - Dixons Carphone, Hikma Financial Times > Other business headlines Multimedia versions of Reuters Top News are now available for: * 3000 Xtra : visit http://topnews.session.rservices.com * BridgeStation: view story .134 For more information on Top News visit http://topnews.reuters.com (Reporting by Alistair Smout)

  • Show Article Details

    The following are the top stories on the New York Times business pages. - The U.S. stock market soared in late trading on Wednesday, shrugging off earlier declines in China and Europe. - Monsanto Co (MON) said on Wednesday that it was abandoning its $47 billion takeover bid for the Swiss agricultural chemical manufacturer Syngenta AG (SYT) after the company rebuffed a newly sweetened offer.

  • Show Article Details

    * Pair bidding against Carlyle, KKR, others. * Carlyle partnered Singapore's GIC. * Rare instance of Temasek and GIC in competing bids. By Saeed Azhar. Singapore state investor Temasek Holdings Ltd has partnered Asia-focused private equity firm MBK Partners to bid for the South Korea arm of British supermarket operator Tesco PLC (TSCDF), two people familiar with the matter told Reuters.

  • Show Article Details

    Asia-focused private equity firm MBK Partners has partnered with Singapore state investor Temasek Holdings to bid for the South Korea arm of British retailer Tesco, two people familiar with the matter told Reuters. The sources declined to be named because the information remained confidential.

  • Show Article Details

    Schlumberger' s planned $12.7 billion, cash-and-stock acquisition of Cameron International (CAM) looks like a natural next step as the biggest oil-field-services companies hunker down amid a serious slump in activity among their customers. The pair has had a joint venture, OneSubsea, for two years. The deal effectively allows the two companies to extract the type of cost savings found there across the rest of their businesses.

  • Show Article Details

    When Japanese doctors Ryuji Ueno and Sachiko Kuno came to Bethesda two decades ago, they already had a drug company back home. They founded what would become Sucampo entirely with their own capital in 1996 to see if they could sell treatments to a much larger American market. Two decades later Sucampo is under new leadership, and is buying out its Japanese predecessor R-Tech Ueno for $278 million in cash and stock. The company announced Wednesday a deal to fully acquire R-Tech Ueno, which currently functions as its manufacturing arm. The deal is slated to conclude in the fourth quarter of 2015.Sucampo hit gold in 2006 when it won federal Food and Drug Adminstration approval to sell Amitiza, a drug that treats chronic constipation. The company went public a year later, and grew by leaps and bounds as its flagship drug proliferated accross the United States.R-Tech Ueno, which is publicly traded in Japan, churns out drugs for the international market from its production facilities across Japan and does some research. Today the bulk of Sucampo’s $115.5 million revenue comes from the sale of Amitiza in the United States, after it is shipped across the Pacific from R-Tech’s factories. “We’re a company right now that isn’t directly involved with our own manufacturing,” said Sucampo chief executive Peter Greenleaf, who took the reins of the company last year. “This is a natural acquisition to get us to a vertically integrated organizational structure.”The acquisition also gives Sucampo access to a range of early-stage drugs in the Japanese company’s pipeline, including early-stage treatments for maladies ranging from eye diseases and cancers.






  • Show Article Details

    The following are the top stories in the Financial Times. Headlines. Monsanto (MON) gives up on $46 bln Syngenta (SYT) deal. Paddy Power to merge with rival Betfair. Angry Birds maker sheds another 260 jobs in effort to stay aloft. Overview. U.S. agribusiness leader Monsanto Co (MON) on Wednesday abandoned pursuit of Swiss rival Syngenta AG (SYT), which had rejected a recently sweetened $47 billion offer.

  • Show Article Details

    Betfair (BTFRF)' s investors may be entering the bonus round. The gaming company on Wednesday announced talks to merge with larger rival Paddy Power. The proposed GBP6 billion deal would create one of the largest of its kind with annual revenues of GBP1.1 billion.

  • Show Article Details

    The following are the top stories on the business pages of British newspapers. The Times. * Paddy Power Plc and rival Betfair Group Plc have announced a potential merger that would create one of the largest public online betting and gambling companies in the world. * Banks and building societies handed out mortgages in July at the fastest pace in almost 18 months. The Guardian.

  • Show Article Details

     Cameron International stock closed up 41.3% to $60.01 on heavy trading volume after the company agreed to be acquired earlier today by Schlumberger in a deal valued at $14.8 billion. Schlumberger stock, however, closed down 3.35% to $70.09, also on heavy volume. The companies agreed to 0.716 Schlumberger shares and $14.44 in cash per each Cameron share.

  • Show Article Details

     Vale stock is up 2.21% to $4.39 in afternoon trading on Wednesday, after the company agreed to sell a mine in Australia to Bloomfield Group and Glencore Plc. The terms of the deal were not disclosed. The sale of the Integra coal mine complex is part of Vale's efforts to exit the thermal coal business in Australia as commodity prices fall.

  • Show Article Details

    Swiss agrichemicals group Syngenta (SYT) said its board unanimously rejected a revised offer from suitor Monsanto (MON), which then dropped its takeover approach. The offer, which Syngenta (SYT) said was worth 433 Swiss francs per share as of the market close on Aug. 25, "significantly undervalued the company and was fraught with execution risk," it said in a statement on Wednesday.

  • Show Article Details

    The following are mergers under. APPROVALS AND WITHDRAWALS. -- Private equity firms 3i Group and AMP Capital Investors to acquire joint control of offshore emergency and rescue services provider Esvagt. -- U.S. grains company Archer Daniels Midland Co (ADM) to acquire starch producer Eaststarch. NEW LISTINGS. None. EXTENSIONS AND OTHER CHANGES. None. FIRST-STAGE REVIEWS BY DEADLINE. AUG 28.

  • Show Article Details

    Betfair outperforms midcaps on merger deal. U.K. stocks dropped Wednesday, settling lower along with other European equities as market enthusiasm over stimulus measures enacted by China faded. The FTSE 100 fell 1.7% to end at 5,979.20, with only six companies closing in positive territory.